| Current Price | $131.38 | Mkt Cap | $10.8B |
|---|---|---|---|
| Open | $123.89 | P/E Ratio | 0.00 |
| Prev. Close | $131.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $123.30 - $131.77 | Volume | 2,688,722 |
| 52-Wk Range | $61.28 - $159.84 | Avg. Daily Vol. | 1,531,078 |
A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.
| Current Price | $131.38 | Mkt Cap | $10.8B |
|---|---|---|---|
| Open | $123.89 | P/E Ratio | 0.00 |
| Prev. Close | $131.38 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $123.30 - $131.77 | Volume | 2,688,722 |
| 52-Wk Range | $61.28 - $159.84 | Avg. Daily Vol. | 1,531,078 |
The best Bull and Bear pitches based on recency and number of recommendations.
Strong revenue growth and a big pipeline make this a good long-term hold.
Short. Biopharma. Sells more stock than has revenues. Revs declining too.
Read the most recent pitches from players about SRPT.
Recs
TMFjimhalley
(< 20)
Submitted: 8/25/2022 2:50:04 PM :
Start Price:
$114.44
NASDAQ:SRPT Score:
+20.25
Strong revenue growth and a big pipeline make this a good long-term hold.
Recs
EKO01
(28.25)
Submitted: 5/28/2020 3:50:26 PM :
Start Price:
$153.80
NASDAQ:SRPT Score:
-44.47
srpt is the future of gene therapy in rare diseases. at the same time it is already strong today with very interesting pipeline and excellent management. momentum (post covid) + secular growt = sustainable growth and important gains. watch out but don't worry about volatility.
Recs
TMFEBCapital
(76.42)
Submitted: 1/28/2019 1:49:05 PM :
Start Price:
$117.60
NASDAQ:SRPT Score:
-37.81
Potential to increase total addressable market from 13% to to 30% of Duchenne muscular dystrophy population by the end of 2020.
Find the members with the highest scoring picks in SRPT.
Newt805 (60.94) Score: +2,875.21
"It's one thing to feel that you're on the right path, but it's another to think that yours is the only path." Paulo Cuelho, novelist IX X XIII XIV XL XLIII
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
|
Newt805 | 60.94 |
|
|
5Y | $4.14 | +3,072.51% | +197.30% | +2,875.21 | 3 Comments |
| ruben7086 | < 20 | 5/10/2012 |
|
5Y | $4.80 | +2,637.08% | +188.04% | +2,449.05 | 0 Comment | |
| rustam5 | 64.61 | 4/18/2012 |
|
5Y | $5.40 | +2,332.96% | +183.35% | +2,149.61 | 0 Comment | |
| embodiedheart | 44.50 | 4/2/2012 |
|
5Y | $6.54 | +1,908.87% | +176.95% | +1,731.91 | 0 Comment | |
| Apprentice15 | 88.84 | 2/8/2012 |
|
3M | $6.54 | +1,908.87% | +191.17% | +1,717.70 | 0 Comment | |
| blashmet | < 20 | 2/8/2012 |
|
5Y | $6.78 | +1,837.76% | +191.92% | +1,645.83 | 0 Comment | |
| benjaeger | 59.88 | 8/8/2011 |
|
1Y | $6.90 | +1,804.06% | +236.75% | +1,567.31 | 0 Comment | |
| Prof3215 | < 20 | 9/16/2011 |
|
5Y | $7.50 | +1,651.73% | +224.59% | +1,427.15 | 1 Comment | |
| TheMadFlea | < 20 | 3/22/2012 |
|
5Y | $8.16 | +1,510.05% | +182.86% | +1,327.19 | 0 Comment | |
| DudeTri | 55.06 | 6/13/2011 |
|
5Y | $8.10 | +1,521.98% | +207.83% | +1,314.14 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
